This HSCI Research Update synthesizes the scientific work published by HSCI Principal Faculty each month. To continue receiving this newsletter, please register as an HSCI Affiliate or Friend by clicking here.

If you are having problems viewing this newletter, click here to view it in your web browser.

Spotlight

In two papers published in Cell, investigators from the Harvard Stem Cell Institute, Massachusetts General Hospital, and Childrens Hospital Boston describe how cloned progenitor cells can differentiate into cardiac muscle, smooth muscle, or endothelial cells.


Research reveals master heart cell

Cardiogenesis requires the generation of endothelial, cardiac, and smooth muscle cells, however the lineage of these cell types remains incompletely understood.

"The mechanism of cardiogenesis has fascinated biologists for two centuries," says Stuart Orkin, who led the team of researchers at Childrens Hospital Boston. "Despite beliefs that the different cells had distinct origins, recent animal experiments have suggested that a large proportion of cells in the mature heart share a common ancestry. To investigate this, we isolated cardiac progenitor cells from early stage mouse embryos and followed their differentiation. Expectedly, the majority of these cells differentiated spontaneously into muscle cells that expand and contract the heart's chambers. But, surprisingly, a subset of the cells adapted a smooth muscle cell fate." These results support the existence of a common precursor for cardiovascular lineages in the mammalian heart.

In a separate study, Kenneth Chien, director of the Harvard Stem Cell Institute's cardiovascular disease program and Massachusetts General Hospital's center for cardiovascular research, and his team used genetic fate-mapping studies to document that ES cell-derived multipotent isl1+ cardiovascular precursors can generate each of these diverse cardiovascular cell types in vivo.

"These progenitor cells offer new prospects for drug discovery and suggest a novel strategy for regeneration of cardiovascular tissue," says Chien. "The results suggest an alternative strategy for achieving the regeneration of distinct heart components that are affected in diverse forms of degenerative heart disease."

The next step will be to translate these findings in mouse models into human cells.

Fig. 1. Model of cellular hierarchy of cardiovascular progenitors and their lineage specification.

Moretti A, Chien KR, et al. Cell. Multipotent Embryonic Isl1(+) Progenitor Cells Lead to Cardiac, Smooth Muscle, and Endothelial Cell Diversification.

Moretti A, Caron L, Nakano A, Lam JT, Bernshausen A, Chen Y, Qyang Y, Bu L, Sasaki M, Martin-Puig S, Sun Y, Evans SM, Laugwitz KL, Chien KR. Multipotent Embryonic Isl1(+) Progenitor Cells Lead to Cardiac, Smooth Muscle, and Endothelial Cell Diversification. Cell. 2006 Nov 20; Read Abstract.

Wu SM, Fujiwara Y, Cibulsky SM, Clapham DE, Lien CL, Schultheiss TM, Orkin SH. Developmental Origin of a Bipotential Myocardial and Smooth Muscle Cell Precursor in the Mammalian Heart. Cell. 2006 Nov 20 Read Abstract.

Review and Commentary Articles

Scientific Papers

Blood Disease

Cancer

Cardiovascular Disease

Development

Immunology

Nervous System Diseases

Skeletal

The Harvard Stem Cell Institute is a scientific collaborative established to fulfill the promise of stem cell biology as the basis for cures and treatments for a wide range of chronic medical conditions.

Visit our website at www.hsci.harvard.edu

If there is anything that you would like to see added to this email alert, please email maureen_mcdonough@harvard.edu.

Photo courtesy of B.D.Colen.
Copyright © 2006 President and Fellows of Harvard College. All rights reserved.